Table 2.
The risk of bias of the included studies using Cochrane Collaboration criteria for quality assessment.
| Item/Author, year | Chang, 2013 | Gupta, 2019 | Kalk, 2020 | Moro, 2018 | Salazar-Austin, 2019 | Taylor, 2013 | Figueroa-Damia, 1998 | Sharma, 2016 | Loveday, 2020 | Czeizel, 2001 |
|---|---|---|---|---|---|---|---|---|---|---|
| Random sequence generation (selection bias) | H | L | H | L | H | L | H | L | H | H |
| Allocation concealment (selection bias) | U | L | H | L | H | L | H | L | H | H |
| Blinding of participants and personnel (performance bias) | H | L | H | L | H | H | H | L | U | L |
| Blinding of outcome assessment (detection bias) | H | L | U | U | U | H | L | L | H | H |
| Incomplete outcome data (attrition bias) | L | L | L | L | H | L | L | L | L | L |
| Selective reporting (reporting bias) | H | U | L | H | H | U | U | L | U | U |
| Other bias | H | L | H | L | U | L | H | U | H | H |
H: high; L: low; U: unclear.